Tracing diseases in biofluids via exosomes.

Novel platform technology ExoPheno  enabling the discovery and validation of disease-specific exosome subpopulations in biofluids. 


Disease-specific exosome targets

Exosomes are the future of routine disease detection

Circulating snapshot of disease biomarker cargo:

  • Constantly secreted by all living cells

  • Protected from enzymatic destruction

  • Found in all biofluids, including blood

Contain rare molecular information (-omics):

  • Proteins

  • miRNA

  • Others

Illlustration of exosomes

Novel exosome liquid biopsy platform ExoPheno


Validation technology, NPQuantumSense:

  • Method to trap and identify target exosomes in biofluid via quantum phenomena generated by proprietary nanogap electrodes

Discovery technology, NPDiscover:

  • Method to isolate exosome subpopulations by origin and disease considering two specific surface markers (or more) via proprietary tagging and release

Illustration of nanogap electrodes on chip



2020 Mursla Ltd.

181 Cambridge Science Park, CB4 0GJ, Cambridge, U.K.

  • Twitter - White Circle
  • LinkedIn - White Circle